GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Globus Medical Inc (NYSE:GMED) » Definitions » EBIT per Share

Globus Medical (Globus Medical) EBIT per Share : $1.86 (TTM As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Globus Medical EBIT per Share?

Globus Medical's EBIT per Share for the three months ended in Dec. 2023 was $0.19. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.86.

During the past 12 months, the average EBIT per Share Growth Rate of Globus Medical was -23.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 15.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 4.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Globus Medical's EBIT per Share or its related term are showing as below:

GMED' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -12.3   Med: 4.4   Max: 15.5
Current: 15.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Globus Medical was 15.50% per year. The lowest was -12.30% per year. And the median was 4.40% per year.

GMED's 3-Year EBIT Growth Rate is ranked better than
61.19% of 724 companies
in the Medical Devices & Instruments industry
Industry Median: 6.75 vs GMED: 15.50

Globus Medical's EBIT for the three months ended in Dec. 2023 was $26 Mil.


Globus Medical EBIT per Share Historical Data

The historical data trend for Globus Medical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Globus Medical EBIT per Share Chart

Globus Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.73 1.14 1.88 2.30 1.76

Globus Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.57 0.68 0.43 0.19

Globus Medical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Globus Medical's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=201.85/114.630
=1.76

Globus Medical's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

EBIT per Share(Q: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=25.954/138.062
=0.19

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Globus Medical  (NYSE:GMED) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Globus Medical EBIT per Share Related Terms

Thank you for viewing the detailed overview of Globus Medical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Globus Medical (Globus Medical) Business Description

Traded in Other Exchanges
Address
2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
Executives
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Dan Wolterman director 3721 VALLEY CENTRE DR, SUITE 500, SAN DIEGO CA 92130
John A Deford director C R BARD INC, 730 CENTRAL AVENUE, MURRAY HILL NJ 07974
Dan Lemaitre director 2 MUSICK, IRVINE CA 92618
Keith W Pfeil officer: SVP, Chief Financial Officer GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Kelly Huller officer: SVP, General Counsel 2560 GENERAL ARMISTEAD AVENUE, AUDOBON PA 19403
David D Davidar director, officer: Vice President, Operations C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
James R Tobin director C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Daniel T Scavilla officer: Senior VP and CFO C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
David M Demski director, officer: President and COO C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Robert Andrew Douglas director 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106
Stephen T Zarrilli director FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Anthony L Williams officer: Senior VP of Bus. Devel. & GC C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Steven Payne officer: Chief Accounting Officer C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
David C Paul director, 10 percent owner, officer: Chief Executive Officer C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403